Table 5.
Spearman's correlation analysis demonstrating the correlation between serum left atrial appendage flow velocity and baseline characteristics (n=65)
| Correlation coefficient (r) | P value | |
|---|---|---|
| Age (y) | −.552 | <.001a |
| Body mass index (kg/m2) | −.056 | .658 |
| Duration of AF (mo) | −.068 | .604 |
| LAVI (mL/m2) | −.052 | .680 |
| Left ventricular end‐diastolic volume (mL) | −.155 | .216 |
| Left ventricular ejection fraction (%) | .178 | .156 |
| Serum galectin‐3 (ng/mL) | −.440 | <.001a |
| Platelet count (×103/μL) | −.103 | .416 |
| Serum creatinine (mg/dL) | −.056 | .661 |
r, Spearman's correlation coefficient; AF, atrial fibrillation; CHADS2, Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, Prior Stroke or TIA or Thromboembolism [doubled]; CHA2DS2‐ VASc, Congestive heart failure, Hypertension, Age ≥75 years [doubled], Diabetes mellitus, Prior Stroke or TIA or thromboembolism [doubled], Vascular disease, Age 65‐74 years, Sex category; LAVI, left atrial volume index.
a
P<.05 denotes statistical significance.